Extremely Rare Primary Gastric Alveolar Rhabdomyosarcoma in an Adult: 18F-FDG PET/CT Findings
PDF
Cite
Share
Request
Interesting Image
E-PUB
2 July 2026

Extremely Rare Primary Gastric Alveolar Rhabdomyosarcoma in an Adult: 18F-FDG PET/CT Findings

Mol Imaging Radionucl Ther. Published online 2 July 2026.
1. University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye
2. University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Radiology, İstanbul, Türkiye
3. University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Clinical Pathology, İstanbul, Türkiye
No information available.
No information available
Received Date: 28.04.2026
Accepted Date: 21.06.2026
E-Pub Date: 02.07.2026
PDF
Cite
Share
Request

Abstract

Approximately 85-90% of all rhabdomyosarcoma (RMS) cases occur in children and adolescents. In adults, RMS accounts for only 2-5% of all soft tissue sarcomas. The annual incidence in adults is 0.3-0.5 per 1,000,000 and is classified as a “very rare tumor.” More than 95% of RMSs are extragastric. Primary gastric RMS is reported extremely rarely in adults, and the estimated incidence is <0.01/1,000,000/year. This rate is <0.01% of all gastric malignancies and <1% of all adult RMSs. We report the 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in an adult with primary gastric alveolar RMS, highlighting the metabolic characteristics of this extraordinarily rare malignancy.

Keywords:
Rhabdomyosarcoma, alveolar rhabdomyosarcoma, 18F-FDG PET/CT, primary gastric rhabdomyosarcoma, rare malignancy

Ethics

Informed Consent: Written informed consent was obtained from the patient for the 18F-FDG PET/CT examination.

Authorship Contributions

Surgical and Medical Practices: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Consept: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Design: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Data Collection or Processing: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Analysis or Interpretation: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Literature Search: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A., Writing: B.Y.B., İ.B., C.L., İ.T.R., E.A., G.A., E.A.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Lairani DJ, Lemfadli DA, Pr Ait Errami PS, Pr Oubaha PK. Primary gastric rhabdomyosarcoma. A case report. Glob Acad J Med Sci. 2020;2:1-3.
2
Hernández E, Tejedor-Tejada J, Sánchez Sanmamed L, Camblor C, Villar Caamaño A, Robles Gaitero S, Groba E. Primary gastric rhabdomyosarcoma. A rare cause of an upper gastrointestinal bleeding. Rev Esp Enferm Dig. 2025;117:476-477.
3
Nakamura N, Suzuki R, Takahashi Y, Uwamori A, Masuda M, Fukui T, Noda Y, Tsuta K, Naganuma M. Primary gastric rrhabdomyosarcoma. Intern Med. 2023;62:3483-3488.
4
Francis J, Young P. Got the GIST? Maybe not! Primary gastric rhabdomyosarcoma (RMS): 2542. Am J Gastroenterol. 2017;112:S1386.
5
Fox KR, Moussa SM, Mitre RJ, Zidar BL, Raves JJ. Clinical and pathologic features of primary gastric rhabdomyosarcoma. Cancer. 1990;66:772-778.
6
Palermo M, Mastronardi LM, García RH, Solari I, Tarsitano FJ. Primary gastric rhabdomyosarcoma. Case report. Acta Gastroenterol Latinoam. 2012;42:131-134.
7
Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091-3102.
8
Bompas E, Campion L, Italiano A, Le Cesne A, Chevreau C, Isambert N, Toulmonde M, Mir O, Ray-Coquard I, Piperno-Neumann S, Saada-Bouzid E, Rios M, Kurtz JE, Delcambre C, Dubray-Longeras P, Duffaud F, Karanian M, Le Loarer F, Soulié P, Penel N, Blay JY. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Med. 2018;7:4023-4035.